Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
- Volume 4
- Issue 7 Suppl
New Drug Class Offers Benefits in Heart Failure
Author(s)Edward P. Havranek, MD
Advertisement
Articles in this issue
over 28 years ago
Participating Facultyover 28 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadeover 28 years ago
Exploring the Benefits Beyond Blood Pressure ControlAdvertisement
Related to this article
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.
The associate editor of Evidence-Based Oncology says the turnover that will follow this week's midterm election calls for renewed engagement from community oncology leaders with members of Congress, due to pressing reimbursement issues.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
How Plans, Clinicians Should Handle Gray-Market Retatrutide
3
IVF Beats IUI for Early Live Births in Unexplained Infertility
4
Early-Onset Cancers Often Found Late as Screening Gaps Persist
5